Anti-Human MAP2K1 Antibody [B288]
Anti-Human MAP2K1 Antibody [B288] with collaborator-tested evidence for WB. Read more ›
["WB"]Product Description
MAP2K1 is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Monoclonal; clone: B288; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: A synthetic phosphopeptide corresponding to residues around Ser218 and Ser222 of the Human MEK1; purification: Protein A; concentration: 1 mg/mL.
Database references: UniProt: Q02750.
Research Use Only.
Key Facts
| Target | MAP2K1 |
| Also known as | MEK, MKK, CFC, MAPKK, PRKMK, MAP2K, CFC3, MAPKK1, MEK1, MKK1, PRKMK1, MAP2K1, Dual specificity mitogen activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 1, ERK activator kinase 1, kinase 1, MAP kinase kinase 1, MAP kinase/Erk kinase 1, MAPK/ERK kinase 1, MAPKK 1, MEK 1, MEKK1, Mitogen activated protein kinase kinase 1, MKK 1, MP2K1, Protein kinase mitogen activated, Protein kinase mitogen activated kinase 1 (MAP kinase kinase 1) |
| Concentration | 1 mg/mL |
| Species reactivity | Human |
| Observed band | 43 kDa |
| Shelf life | 12 months from shipping dates |
| Research area | Signal Transduction |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | |
|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.